Alerts will be sent to your verified email
Verify EmailSUNPHARMA
| 
                  Sun Pharma Inds. 
             | 
            
            
                  Cipla 
             | 
            
            
                  Torrent Pharma 
             | 
            
        |
|---|---|---|---|
| 
          
            
                
                
                
                    
                
                 
            
            Operational Metrics
         
     | 
    
    
        
            |||
| 
          
            
                
                
                
                    
                
                 
            
            Pharmaceuticals
         
     | 
    
    
        
            |||
| 
          
            
                
                
                
                    
                
                 
            
            Number of ANDA's Filed in USA
         
     | 
     
         
            661.0 . | 285.0 . | 172.0 . | 
| 
          
            
            Number of ANDA's Approved By USFDA
         
     | 
     
         
            542.0 . | 225.0 . | 132.0 . | 
| 
          
            
            Domestic Sales Growth - YoY
         
     | 
     
         
            12.0 % | 6.8 % | 12.3 % | 
| 
          
            
            US DMF Filings
         
     | 
     
         
            529.0 . | 2472.0 . | n/a | 
| 
          
            
            US DMF Approval
         
     | 
     
         
            401.0 . | n/a | n/a | 
| 
          
            
            R&D as a % of Total Sales
         
     | 
     
         
            6.5 % | 7.1 % | 5.0 % | 
| 
          
            
                
                
                
                    
                
                 
            
            Financials
         
     | 
    
    
        
            |||
| 
          
            
                
                
                
                    
                
                 
            
            5 yr Average ROE
         
     | 
     
         
            11.67 % | 13.9 % | 20.79 % | 
| 
          
            
            5yr average Equity Multiplier
         
     | 
     
         
            1.33 | 1.25 | 2.16 | 
| 
          
            
            5yr Average Asset Turnover Ratio
         
     | 
     
         
            0.57 | 0.78 | 0.69 | 
| 
          
            
            5yr Avg Net Profit Margin
         
     | 
     
         
            15.4 % | 14.31 % | 13.95 % | 
| 
          
            
            Price to Book
         
     | 
     
         
            5.67 | 3.71 | 16.18 | 
| 
          
            
            P/E
         
     | 
     
         
            39.49 | 22.44 | 61.34 | 
| 
          
            
                
                
                
                    
                
                 
            
            5yr Avg Cash Conversion Cycle
         
     | 
     
         
            -46.88 Days | -4.31 Days | -186.79 Days | 
| 
          
            
            Inventory Days
         
     | 
     
         
            65.22 Days | 57.83 Days | 54.98 Days | 
| 
          
            
            Days Receivable
         
     | 
     
         
            84.33 Days | 50.64 Days | 40.18 Days | 
| 
          
            
            Days Payable
         
     | 
     
         
            175.41 Days | 105.99 Days | 298.32 Days | 
| 
          
            
            5yr Average Interest Coverage Ratio
         
     | 
     
         
            44.12 | 53.73 | 7.38 | 
| 
          
            
            5yr Avg ROCE
         
     | 
     
         
            18.0 % | 19.36 % | 25.78 % | 
| 
          
            
            5yr Avg Operating Profit Margin
         
     | 
     
         
            26.44 % | 23.02 % | 30.49 % | 
| 
          
            
            5 yr average Debt to Equity
         
     | 
     
         
            0.06 | 0.03 | 0.66 | 
| 
          
            
            5yr CAGR Net Profit
         
     | 
     
         
            30.35 % | 17.0 % | 8.83 % | 
| 
          
            
            5yr Average Return on Assets
         
     | 
     
         
            8.92 % | 11.19 % | 9.73 % | 
| 
          
            
                
                
                
                    
                
                 
            
            Shareholdings
         
     | 
    
    
        
            |||
| 
          
            
            Promoter Holding
         
     | 
     
         
            54.48 % | 29.21 % | 68.31 % | 
| 
          
            
            Share Pledged by Promoters
         
     | 
     
         
            0.97 % | 0.0 | 0.0 | 
| 
          
            
            Change in Promoter Holding (3 Yrs)
         
     | 
     
         
            0.0 | -4.4 % | -2.94 % | 
| 
          
            
            Change in Mutual Fund Holding (3 Yrs)
         
     | 
     
         
            0.19 % | 6.45 % | -1.6 % | 
| 
                          Sun Pharma Inds. 
                     | 
                
                    
                          Cipla 
                     | 
                
                    
                          Torrent Pharma 
                     | 
                
            |
|---|---|---|---|
| 
              
                Product Wise Break-Up
             
         | 
         
            
                
                    
                         Product Wise Break-Up 
                        
  | 
            
                
                    
                         Product Wise Break-Up 
                        
  | 
            
                
                    
                         Product Wise Break-Up 
                        
  | 
            
        
    
| 
              
                Therapeutic Area Wise Break-Up - Domestic
             
         | 
         
            
                
                    
                         Therapeutic Area Wise Break-Up - Domestic 
                        
  | 
            
                
                    
                         Therapeutic Area Wise Break-Up - Domestic 
                        
  | 
            
                
                    
                         - 
                    
                 | 
            
        
    
| 
              
                Location Wise Break-Up
             
         | 
         
            
                
                    
                         Location Wise Break-Up 
                        
  | 
            
                
                    
                         Location Wise Break-Up 
                        
  | 
            
                
                    
                         Location Wise Break-Up 
                        
  |